Targocid 200 Mg Injection, a prescription drug, is manufactured in various forms such as Injection. Primarily, it is used for the treatment of Endocarditis. Other than this, Targocid 200 Mg Injection has some other therapeutic uses, which have been discussed ahead.
The correct dosage of Targocid 200 Mg Injection depends on the patient's age, gender, and medical history. Individual symptoms and route of administration also determines the right dosage. For detailed information on this, read through the dosage section.
Common side effects of Targocid 200 Mg Injection include Rash, Itching or burning, Fever. Besides the aforementioned side effects, there are other adverse effects of Targocid 200 Mg Injection as well, which are listed below. Such side effects of Targocid 200 Mg Injection normally do not last long and go away once the treatment is completed. However, if these continue for a longer time, consult your doctor right away.
In addition, Targocid 200 Mg Injection's effect is Unknown during pregnancy and Unknown for lactating mothers. In addition, Targocid 200 Mg Injection's effects on the liver, heart and kidney are discussed below in the Targocid 200 Mg Injection related warnings section.
Other contraindications of Targocid 200 Mg Injection have been discussed in the sections ahead.
Drug interactions for Targocid 200 Mg Injection have been reported in the medical literature. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Targocid 200 Mg Injection is considered not safe while driving, and is not addictive.
Targocid 200 Mg Injection is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Infant (1 month to 2 years) |
|
Neonates (0 to 1 month) |
|
Is the use of Targocid 200 Mg Injection safe for pregnant women?
It is not known what effect Targocid will have on pregnant women, because no research work has been carried out on this till date.
Is the use of Targocid 200 Mg Injection safe during breastfeeding?
Information about safety of Targocid for women who are breastfeeding is not available since scientific research on this is yet to be done.
What is the effect of Targocid 200 Mg Injection on the Kidneys?
Targocid rarely harms the kidneys.
What is the effect of Targocid 200 Mg Injection on the Liver?
Targocid is not harmful for the liver.
What is the effect of Targocid 200 Mg Injection on the Heart?
Targocid is completely safe for the heart.
Targocid 200 Mg Injection should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Targocid 200 Mg Injection unless your doctor advises you to do so -
Is this Targocid 200 Mg Injection habit forming or addictive?
No, there is no any evidence that Targocid 200 Mg Injection is addictive.
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Targocid 200 Mg Injection. So it is best to avoid driving.
Is it safe?
Targocid 200 Mg Injection should be used only after doctor's advice.
Is it able to treat mental disorders?
There is no benefit of taking Targocid 200 Mg Injection for mental disorders.
Interaction between Food and Targocid 200 Mg Injection
Taking Targocid 200 Mg Injection with food does not harm your health.
Interaction between Alcohol and Targocid 200 Mg Injection
Due to lack of research, there is no information about the side effects of taking Targocid 200 Mg Injection with alcohol.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 758